Report copyright - Bases biológicas del cáncer de pulmón. Caracterización ... · KEYNOTE-024: Pembrolizumab . vs. quimioterapia: OS . Reck M et al, Future Oncol. (2019) 15(12), 1363–1383. Fenotipos
Please pass captcha verification before submit form
Please pass captcha verification before submit form